Factors Affecting BAT Activation in PET/CT
NCT05577299 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80
Last updated 2022-10-13
Summary
The aim of the present study is to evaluate the factors affecting BAT activation in 18F-FDG-PET/CT in different tumours
Conditions
- Factors Affecting BAT Activation in PET/CT
Interventions
- DEVICE
-
PET/CT
18F-fluorodeoxyglucose positron emission tomography/computed tomography (18FFDG PET/CT) is a non-invasive imaging modality used for staging and surveillance of various types of malignancies through imaging of glucose metabolism in cancer cells.
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-11-01
- Primary Completion
- 2025-08-01
- Completion
- 2025-10-01
More Related Trials
-
Detection of Brown Adipose Tissue by Magnetic Resonance Imaging
NCT02237872 ·Status: COMPLETED
-
F-18-OMFD-PET for Radiotherapy Treatment Planning and Evaluation of Early Therapy Response
NCT00180193 ·Status: TERMINATED
-
F-18 FDG PET/CT and CT in Initial Staging of Non-small Lung Cancer
NCT06789562 ·Status: NOT_YET_RECRUITING
-
Assessment of 4D 18F-FDG PET-CT in Radiotherapy for Non Small Cell Lung Cancers
NCT01421953 ·Status: COMPLETED ·Phase: NA
-
FLT-PET for Early Detection of Relapse in Patients With Irradiated Lung Cancer
NCT02995889 ·Status: COMPLETED ·Phase: NA
-
Role of FDG PET/CT in Patients With Metastasis of Unknown Origin
NCT06055764 ·Status: NOT_YET_RECRUITING
-
An International Study on the Use of PET/CT in Radiotherapy Planning in Low and Middle Income Countries
NCT02247713 ·Status: UNKNOWN
-
The Utility of FDG-PET for Radiation Treatment in NSCLC
NCT00385164 ·Status: UNKNOWN
-
PET-CT in Lymphoma Among the Eldery
NCT07259941 ·Status: NOT_YET_RECRUITING
-
Application of Al18F-NOTA-FAPI PET/CT in Malignant Tumors Expressing Fibroblast-activated Proteins
NCT05749302 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
18F-FAPI-04 PET/CT and PET/MR in Patients With Various Types of Malignant Tumors
NCT06557590 ·Status: RECRUITING
-
FLT-PET/DW-MRI for Detection of Brain Metastases and Early Therapy Evaluation in Patients With Small Cell Lung Cancer
NCT02995902 ·Status: COMPLETED ·Phase: NA
-
PET-DECT for Staging and Imaged Based Radiotherapy Planning in Lung Cancer
NCT03146117 ·Status: TERMINATED
-
18F-FDG Uptake Measurements in Malignant Solid Tumors on PET/CT and PET/MR
NCT02717572 ·Status: COMPLETED ·Phase: PHASE1
-
18F-AlF-FAPi-04 PET/CT Imaging in Patients With Solid Tumor
NCT06126705 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Application of Al18F-octreotide PET/CT in Tumors With Positive SSTR Expression
NCT05749289 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Contribution of 18FDG PET-Scan in Tumour Volume Determination in Patients Operated of Breast Cancer
NCT01621529 ·Status: COMPLETED
-
Study for Quantitative Analysis of the Recovered COVID-19 Patients by 18F-FDG-PET/CT
NCT04519255 ·Status: UNKNOWN
-
FDG-PET/CT for Simulation and Radiation Treatment Planning of Early Breast Cancer
NCT01432002 ·Status: UNKNOWN
-
Clinical Study of 18F-FAPI-RGD in Breast Tumors
NCT05976620 ·Status: COMPLETED
-
Usefulness of 18F-FDG PET/CT in the Initial Staging and Surveillance of Endometrial Cancer Patients
NCT05056259 ·Status: UNKNOWN
-
18F-FSPG PET/CT Imaging in Patients With Cancers
NCT03144622 ·Status: UNKNOWN
-
Perfusion and Hypoxia Evaluation in Tumors Using 18F-FDG PET/CT
NCT03373994 ·Status: UNKNOWN
-
FDG-PET/CT vs. CT for Monitoring Metastatic Breast Cancer
NCT06877949 ·Status: RECRUITING ·Phase: NA
-
PET/CT Evaluation of Treatment Response in Breast Cancer
NCT01222416 ·Status: TERMINATED ·Phase: NA